19-49818343-T-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_030973.4(MED25):c.2T>G(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
MED25
NM_030973.4 start_lost
NM_030973.4 start_lost
Scores
6
6
4
Clinical Significance
Conservation
PhyloP100: 4.06
Genes affected
MED25 (HGNC:28845): (mediator complex subunit 25) This gene encodes a component of the transcriptional coactivator complex termed the Mediator complex. This complex is required for transcription of most RNA polymerase II-dependent genes. The encoded protein plays a role in chromatin modification and in preinitiation complex assembly. Mutations in this gene are associated with Charcot-Marie-Tooth disease type 2B2. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-49818343-T-G is Pathogenic according to our data. Variant chr19-49818343-T-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3063666.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MED25 | NM_030973.4 | c.2T>G | p.Met1? | start_lost | 1/18 | ENST00000312865.10 | NP_112235.2 | |
MED25 | NM_001378355.1 | c.2T>G | p.Met1? | start_lost | 1/18 | NP_001365284.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED25 | ENST00000312865.10 | c.2T>G | p.Met1? | start_lost | 1/18 | 1 | NM_030973.4 | ENSP00000326767 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 24, 2024 | Variant summary: MED25 c.2T>G (p.Met1Arg) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. A rare, homozygous missense variant p.Tyr39Cys, upstream of the next downstream in-frame Met104, has been reported in at-least 4 families with Basel-Vanagait-Smirin-Yosef syndrome, and segregated with disease; subsequent functional study found p.Tyr39Cys impaired MED25 interaction with the Mediator complex in mammalian cells (PMID: 25792360, ClinVar ID 203445). The current variant was absent in 203948 control chromosomes. To our knowledge, no occurrence of c.2T>G in individuals affected with Congenital Cataract-Microcephaly Flammeus Simplex-Severe Intellectual Disability Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;.;T;T;T;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;.
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D
PROVEAN
Uncertain
.;.;.;.;N;.;N;.;.
REVEL
Pathogenic
Sift
Pathogenic
.;.;.;.;D;.;D;.;.
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D
Polyphen
0.93
.;.;.;.;P;.;.;.;.
Vest4
MutPred
Gain of methylation at M1 (P = 0.0173);Gain of methylation at M1 (P = 0.0173);Gain of methylation at M1 (P = 0.0173);Gain of methylation at M1 (P = 0.0173);Gain of methylation at M1 (P = 0.0173);Gain of methylation at M1 (P = 0.0173);Gain of methylation at M1 (P = 0.0173);Gain of methylation at M1 (P = 0.0173);Gain of methylation at M1 (P = 0.0173);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.